Global Coronavirus Partnering 2023: Trends, Financials and Key Players for Every Deal Since 2016

Dublin, April 07, 2023 (GLOBE NEWSWIRE) -- The "Global Coronavirus Partnering 2016-2023" report has been added to * ResearchAndMarkets.com's* offering.

Global Coronavirus Partnering 2016 to 2023 provides the full collection of coronavirus disease deals signed between the world's pharmaceutical and biotechnology companies since 2016.

· Trends in coronavirus partnering deals
· Financial deal terms for headline, upfront and royalty by stage of development
· Coronavirus partnering agreement structure
· Coronavirus partnering contract documents
· Top coronavirus deals by value
· Most active coronavirus dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive coronavirus disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering coronavirus deals.

The report presents financial deal terms values for coronavirus deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of coronavirus dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in coronavirus dealmaking since 2016 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading coronavirus deals since 2016. Deals are listed by headline value. The chapter includes the top 25 most active coronavirus dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to coronavirus deals since 2016 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all coronavirus partnering deals by specific coronavirus target announced since 2016. The chapter is organized by specific coronavirus therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all coronavirus partnering deals signed and announced since 2016. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in coronavirus partnering and dealmaking since 2016.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of coronavirus technologies and products.

*Report scope*

Global Coronavirus Partnering 2016 to 2023 is intended to provide the reader with an in-depth understanding and access to coronavirus trends and structure of deals entered into by leading companies worldwide.

*Global Coronavirus Partnering 2016 to 2023 includes:*

· Trends in coronavirus dealmaking in the biopharma industry since 2016
· Access to headline, upfront, milestone and royalty data
· Access to numerous coronavirus deal contract documents
· Comprehensive access to over 1500 coronavirus deal records
· The leading coronavirus deals by value since 2016
· Most active coronavirus dealmakers since 2016

*In Global Coronavirus Partnering 2016 to 2023, available deals and contracts are listed by:*

· Headline value
· Upfront payment value
· Royalty rate value
· Stage of development at signing
· Deal component type
· Technology type
· Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Coronavirus Partnering 2016-2023 report provides comprehensive access to available deals and contract documents for over 1500 coronavirus deals.

*Analyzing actual contract agreements allows assessment of the following:*

· What are the precise rights granted or optioned?
· What is actually granted by the agreement to the partner company?
· What exclusivity is granted?
· What is the payment structure for the deal?
· How are the sales and payments audited?
· What is the deal term?
· How are the key terms of the agreement defined?
· How are IPRs handled and owned?
· Who is responsible for commercialization?
· Who is responsible for development, supply, and manufacture?
· How is confidentiality and publication managed?
· How are disputes to be resolved?
· Under what conditions can the deal be terminated?
· What happens when there is a change of ownership?
· What sublicensing and subcontracting provisions have been agreed?
· Which boilerplate clauses does the company insist upon?
· Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
· Which jurisdiction does the company insist upon for agreement law?

*Selection of Companies Mentioned*
· 1health.io
· 3D BioMed
· 3M
· 3rd People's Hospital of Shenzhen
· 7 Hills Pharma
· 9 Meters Biopharma
· 10X Genomics
· A2A Pharmaceuticals
· Aardvark Therapeutics
· Aarhus University
· Abbott Laboratories
· Abbott Rapid Diagnostics
· Abbvie
· AbCellera
· ABEC
· ABL Bio
· Ablexis
· Abnova
· Aboundbio
· Absolute Antibody
· Abzena
· Academy of Military Medical Sciences (China)
· Accelerated Enrollment Solutions
· Accelerate Diagnostics
· Access BIO
· Acer Therapeutics
· Active Motif
· Acuant
· Adamis Pharmaceuticals
· Adaptive Biotechnologies
· Adaptive Phage Therapeutics
· AdaptVac
· Adeptrix
· Adial Pharmaceuticals
· Aditx Therapeutics
· Adjuvance Technologies
· ADMA Biologics
· ADS
· Advaccine Biotechnology
· Advanced Regenerative Manufacturing Institute
· Advanced Remote Monitoring
· Advarra
· AdventHealth
· Advent International
· Aegea Biotechnologies
· Aegis Life
· Aerogen
· Aerpio Pharmaceuticals
· Aetion
· Affinity Biosciences
· AffyXell Therapeutics
· Africa Centres for Disease Control and Prevention
· Africa Medical Supplies Platform
· Africa Union
· AGC Biologics
· Age Labs
· AgeX Therapeutics
· Agile Biodetection
· AID Genomics
· AIkido Pharma
· AIM ImmunoTech
· Airway Therapeutics
· Ajinomoto Bio-Pharma Services
· Akers Biosciences
· Akron Biotechnology
· Akshaya Bio
· Akston Biosciences
· Albany Molecular Research
· Alberta Cell Therapy Manufacturing
· Albert Einstein College of Medicine
· Algernon Pharmaceuticals
· Aligos Therapeutics
· AlivaMab Discovery Services
· AlloVir
· AllStar Health Brands
· Alnylam Pharmaceuticals
· Alpha-Tec Systems
· Alphamab Biopharmaceuticals
· Altimmune
· Altum Pharmaceuticals
· American Association for Laboratory Accreditation
· American College of Chest Physicians
· American Diabetes Association
· American Medical Depot
· Amerimmune
· AmerisourceBergen
· Ametek
· Amgen
· AMS
· Amyndas Pharmaceuticals
· Amyris
· ANA Therapeutics
· AnGes MG
· Anixa Biosciences
· AnteoTech
· Apollo Med Innovations
· Appili Therapeutics
· Apple
· Applied Biology
· Applied Botanics
· Applied DNA Sciences
· Aptorum Group
· Aragen Bioscience
· Arbor Biosciences
· Arches Research
· Arctoris
· Arcturus Therapeutics
· Ardigen
· Ares Genetics
· Argonne National Laboratory
· Ariadne Genomics
· Armed Forces Medical Research Institute
· ArtemiLife
· AstraZeneca
· Atea Pharmaceuticals
· Atomo Diagnostics
· Atreca
· Atrys Health
· Attana
· ATUM
· Audax Medical
· Augmenta
· AuraVax Therapeutics
· Aurobindo Pharma
· Australian Medical Research Institute
· Austrian Research Promotion Agency
· Avacta
· Avalon GloboCare
· Avellino Labs
· Avera McKennan
· Aveshka
· Avid Bioservices
· Avricore Health
· Avrok Laboratories
· AXIM Biotechnologies
· Axiom Real-Time Metrics
· Aytu BioScience
· AzurRx BioPharma
· Babson Diagnostics
· Bachem
· Barbara Ann Karmanos Cancer Institute
· BASE10 Genetics
· Batavia Biosciences
· Battelle
· Baxter International
· Baylor College
· Baylor College of Medicine
· BBI Solutions
· BC Neuroimmunology
· BC Platforms
· Beckman Coulter
· Becton Dickinson
· BeiGene
· Beijing Genomics Institute (BGI)
· Belkin
· Benchmark Electronics
· Berg
· Berkeley Lights
· Beroni Group
· Best Supplies
· Be The Match BioTherapies
· Beth Israel Deaconess Medical Center
· BetterLife Pharma
· Bharat Biotech
· Bill and Melinda Gates Foundation
· BillionToOne
· Binex
· Bintai Kinden
· Binx Health
· Bio-Rad Laboratories
· Bio-Techne
· BioCanna Healthcare
· Biocept
· BioCheck
· BioComo
· Biocom Purchasing Group
· BioCryst Pharmaceuticals
· Biodesix
· Biodextris
· Bioforum
· Biogen
· Biohit Healthcare
· BioIQ
· BioLab Sciences
· Biolase
· BioLife Solutions
· BioMatrix Specialty Pharmacy
· Biomedical Advanced Research and Development Authority
· Biomeme
· Biomerica
· BioNTech
· BioPharma Plasma
· Bio Products Laboratory
· BioReference Laboratories
· BioSig Technologies
· BioSure
· BioSymetrics
· BioSyntagma
· Biotechnology Industry Research Assistance Council
· BioTecon Diagnostics
· BioTek reMEDys
· Biotest
· Blanver
· Bluejay Diagnostics
· BlueWillow Biologics
· Boca Biolistics
· Boeing Company
· Bold Therapeutics
· Booz Allen
· BPL Medical Technologies
· BravoVax
· BreathTech
· Brickell Biotech
· Brigham and Women's Hospital
· Brighton Biotech
· Brii Biosciences
· Brik
· Briotech
· Bristol-Myers Squibb
· Brown University
· Bruker
· BTG
· Buoy Health
· Burkhan Group
· BurstIQ
· Butantan Institute
· California Institute for Biomedical Research
· Calvert Labs
· Cambridge Blockchain
· Cambridge Consultants
· Canabo Medical Clinics
· Canadian Institutes of Health Research
· Canary Health Technologies
· Capricor Therapeutics
· Care Access Research
· CareDx
· Cascade Chemistry
· Catalent
· Catholic University Leuven
· CCT Research
· Ceapro
· Cellect Biotechnology
· Cellex
· CellSafe
· Celonic
· Celularity
· Cenetron
· Centene
· Centers for Disease Control and Prevention
· Centogene
· Central Association for the Blind and Visually Impaired
· Centre for Human Drug Research
· Cepheid
· Certara
· Chan Zuckerberg Initiative
· Chargeurs
· Charite Universitatsmedizin Berlin
· Chembio Diagnostics
· Chimeron Bio
· Chinese Academy of Sciences
· ChromaDex
· Chugai Pharmaceutical
· Cigna Healthcare
· CimCure
· Ciox Health
· Cipla
· Circuit Clinical
· CIRION BioPharma Research
· Citius Pharmaceuticals
· City College of New York
· City of Corpus Christi
· CLEAR
· Cleared4
· ClearMask
· Cleveland Clinic
· ClinCapture
· Clinical Trial and Consulting Services
· Clinton Health Access Initiative
· Clorox Company
· Clover Biopharmaceuticals
· CN Bio
· CNS Pharmaceuticals
· Co-Diagnostics
· Coalition for Epidemic Preparedness Innovations
· Cobra Biologics
· Cocrystal Pharma
· Codagenix
· Codiak BioSciences
· CohBar
· Columbia University
· Commonwealth of Pennsylvania
· Confirm BioSciences
· ConserV Bioscience
· Contakt World Technologies
· Copan Diagnostics
· Cord Blood Registry
· Corden Pharma
· Corona Diagnostics
· Corpometria Institute
· Cosmo Pharmaceuticals
· Covar Pharmaceuticals
· COVAX
· COVAXX
· Covistat
· CPT Medical
· CQuentia
· Creoptix
· Cristal Therapeutics
· Cromos Pharma
· CSIRO
· CSL
· CSL Behring
· Cubic
· Curative
· Curetis
· CureVac
· Current Health
· CVC
· CVD Equipment
· Cyclacel Pharmaceuticals
· Cyclica
· Cyclolab
· Cystron Biotech
· Cytiva
· CytoAgents
· Cytocom
· Cytodyn
· CytoSorbents
· CytoVale
· Cytovance Biologics
· CYTOVIA Therapeutics
· Cyxone
· Daewoong Pharmaceutical
· Dalberg
· Dalton Pharma Services
· Dartmouth-Hitchcock Medical Center
· Dascena
· Daxor
· Decision Diagnostics
· deCODE Genetics
· Defense Advanced Research Projects Agency
· Defense Threat Reduction Agency
· Dell Medical School
· Delpharm
· Department of Defence
· Department of Defense
· Department of Health and Human Services
· DiaSorin
· Diffusion Pharmaceuticals
· DiNonA
· Diomics
· DKSH
· DMTC
· DNA Link
· DnaNudge
· Donnelley Financial Solutions
· Dr. Reddy's Laboratories
· Drawbridge Health
· Dr Ho Now Health Products
· DSG
· Duality Technologies
· Duke-NUS Graduate Medical School Singapore
· Dyadic International
· Dymax
· Dynasty Castle Investments
· Dynavax Technologies
· DynPort Vaccine Company
· E25Bio
· Eckerd College
· Ecolog International
· Edesa Biotech
· Eisai
· EKF Diagnostics
· Elasmogen
· Eli Lilly
· Ellume
· Emerald Organic Growth
· Emergent BioSolutions
· Emergex Vaccines
· Emery Pharma
· Emory Healthcare
· Emory University
· Empatica
· Empowered Diagnostics
· Emulate
· Ender Diagnostics
· Endo International
· Enesi Pharma
· Enlivex
· Ennaid Therapeutics
· Entos Pharmaceuticals
· Epidemiologic Solutions
· Epivax
· EpiVax Therapeutics
· Epygen Biotech
· Equilab International
· Erasmus University Medical Center
· Ethris
· Eurobio
· European Biomedical Research Institute of Salerno
· European Commission
· European Prevention Center
· European Union
· EUSA Pharma
· EverlyWell
· Eversana
· Evotec
· EVQLV
· Evvivax
· Ewha Womans University
· Exagen Diagnostics
· Excivion
· ExpreS2ion Biotechnologies
· Express Scripts
· ExThera Medical
· Exyte
· FairJourney Biologics
· Fareva Holding
· Farmacore Biotechnology
· FarmaMondo Group
· Ferozsons Laboratories
· FibroGenesis
· Finnish Institute for Health and Welfare
· Fio
· First Wave Bio
· Fishbowl Warehouse
· FitBit
· Flirtey
· Florence
· Florica Therapeutics
· FlowMetric Life Sciences
· Flowserve
· FluGen
· Fluidigm
· Fluxergy
· Food and Drug Administration (FDA)
· Forsitech
· Fosun Pharmaceutical
· Frederick National Laboratory For Cancer Research
· Fred Hutchinson Cancer Research Center
· Frontier Scientific Services
· Fujifilm
· Fujifilm Diosynth Biotechnologies
· FUJIFILM SonoSite
· Fujirebio Diagnostics
· Fulgent Genetics
· Galenvs Sciences
· Gamaleya National Center
· GAVI Alliance
· GBS
· GC Pharma
· GE Healthcare
· GEn1E Lifesciences
· Genentech
· GeneOne Life Science
· General Motors
· Generation Biotech
· Generex Biotechnology
· Genetic Technologies
· Geneva Foundation
· Genevant Sciences
· Genexine
For more information about this report visit https://www.researchandmarkets.com/r/97xpro

*About ResearchAndMarkets.com*
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900